RxDoctor Payments DataLook up a doctor →

Younghoon Cho

Plastic Surgery · Houston, TXNPI 1427137694

Payments from drug & device makers

$1,330,690in general payments, 2019–2025

Across 1,247 payments — averaging $1067.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$985K
  • Galderma Laboratories, L.p.$332K
  • Merz North America, Inc.$12K
  • TELA Bio, Inc.$516
  • Tepha Inc$447
  • Revance Therapeutics, Inc.$397
  • plus $583 from 4 others
$5,319in research payments, 2019–2025

Across 1 payment — averaging $5318.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$5K

What the payments were for

  • Consulting fees$276,77523%
  • Speaking & faculty fees$812,11366%
  • Travel & lodging$82,3617%
  • Food & beverage$27,7552%
  • Education$21,3742%
  • Gifts$2,7000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,330,690 in reported general payments places this provider in the 95th percentile of 337 plastic surgery providers in Texas.

See all plastic surgery providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib28$603
Doxycycline Hyclate23$305
Gabapentin28$77
Tramadol Hcl20$66
Diazepam13$57

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →